Cross-Framework Mapping

6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673)vsFDA Quality Management System Regulation (QMSR)

See exactly how 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls map to FDA Quality Management System Regulation (QMSR). Pre-computed mappings, identified gaps, and coverage analysis.

18
Controls Mapped
23
Gaps Found
24%
Coverage

According to the TheArtOfService Compliance Knowledge Graph:

6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) maps to FDA Quality Management System Regulation (QMSR) with 24% coverage across 11 directly mapped controls. Analysis of 41 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls identifies 32 compliance gaps — primarily concentrated in General Provisions.

Source: TheArtOfService Knowledge Graph | 41 controls analysed | 693 frameworks | 819K+ cross-framework mappings

Control Mappings

Showing 18 of 18 mapped controls across 4 domains. Sign up to explore all 819K+ mappings across 693 frameworks.

General Provisions(3 mappings)

Art. 2Consent Definition
ISO 13485 Cl. 5.5Responsibility and Authority
Art. 4Participating Institutions
ISO 13485 Cl. 5.5Responsibility and Authority
Part 1, Sec. 4Application and Scope
ISO 13485 Cl. 5.5Responsibility and Authority

Criminal Offences(1 mappings)

Art. 4Participating Institutions
ISO 13485 Cl. 5.5Responsibility and Authority

Liability of Legal Persons(1 mappings)

Art. 8Data Categories
ISO 13485 Cl. 5.5Responsibility and Authority

Implementation(13 mappings)

BS65000-IM-01Resilience Assessment
AQAP-5.7Dependability Requirements
BS65000-IM-03Continuous Improvement3 targets
AQAP-5.7Dependability Requirements
ISO 13485 Cl. 4.1General QMS Requirements
ISO 13485 Cl. 8.5.2Corrective Action (CAPA)
FATF-TR-IMP-03VASP AML/CFT
ISO 13485 Cl. 5.5Responsibility and Authority
ISO-8000-IMP-02Quality Improvement2 targets
ISO 13485 Cl. 4.1General QMS Requirements
ISO 13485 Cl. 8.5.2Corrective Action (CAPA)
ISO-8000-IMP-03Sector Applications4 targets
ISO 13485 Cl. 7.3.1Design and Development Planning
ISO 13485 Cl. 7.4Purchasing Controls
§ 820.10(b)Device Tracking
§ 820.10(c)Medical Device Reporting
PBD-IMP-03Organisational Integration2 targets
ISO 13485 Cl. 4.1General QMS Requirements
ISO 13485 Cl. 8.5.2Corrective Action (CAPA)

Related Comparisons

Other 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) comparisons

Other FDA Quality Management System Regulation (QMSR) comparisons

Stop Paying Consultants to Read Spreadsheets

AI-powered compliance intelligence across 693 frameworks — at a fraction of consulting costs.

$0/forever

Free

  • 693 framework browser
  • Cross-framework mappings (819K+)
  • 824 compliance assessments
  • 3 AI queries & searches per day
Get Started Free
Recommended
$49/month

Professional

  • Unlimited AI Compliance Advisory
  • Unlimited full-text search
  • Framework self-assessment
  • PDF, Excel & CSV exports
Start 7-Day Free Trial →

What are the key differences between 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) and FDA Quality Management System Regulation (QMSR)?

6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) has 41 controls across its framework, while FDA Quality Management System Regulation (QMSR) covers 34 controls. Direct mapping analysis identifies 11 overlapping controls (24% coverage). The frameworks diverge most significantly in General Provisions, where 15 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls have no direct FDA Quality Management System Regulation (QMSR) equivalent.

How many controls map between 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) and FDA Quality Management System Regulation (QMSR)?

Of 41 total 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls, 11 map directly to FDA Quality Management System Regulation (QMSR) controls — representing 24% coverage. The remaining 32 controls represent compliance gaps requiring additional documentation or compensating controls to satisfy both frameworks simultaneously.

What are the compliance gaps when mapping 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) to FDA Quality Management System Regulation (QMSR)?

32 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) controls have no direct equivalent in FDA Quality Management System Regulation (QMSR). The highest concentration of gaps is in General Provisions with 15 unmapped controls. These gaps represent areas where additional controls, policies, or documentation must be created to achieve compliance with both frameworks.

Which control domains have the most gaps between 6th Anti-Money Laundering Directive (AMLD6, Directive (EU) 2018/1673) and FDA Quality Management System Regulation (QMSR)?

The domain with the highest gap count is General Provisions (15 gaps). Export the full domain-by-domain gap breakdown via the Professional tier to generate a prioritised remediation roadmap.

This platform provides educational compliance tools, not legal, regulatory, or professional compliance advice. Cross-framework mappings are AI-assisted interpretations and do not reproduce or replace official standards. Framework names and trademarks belong to their respective owners. Consult qualified professionals for your specific compliance requirements. See our Terms of Service.